مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies.
Normal view MARC view ISBD view

A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. [electronic resource]

By:
  • Kim, S Y
Contributor(s):
  • Theunissen, J-W
  • Balibalos, J
  • Liao-Chan, S
  • Babcock, M C
  • Wong, T
  • Cairns, B
  • Gonzalez, D
  • van der Horst, E H
  • Perez, M
  • Levashova, Z
  • Chinn, L
  • D'Alessio, J A
  • Flory, M
  • Bermudez, A
  • Jackson, D Y
  • Ha, E
  • Monteon, J
  • Bruhns, M F
  • Chen, G
  • Migone, T-S
Producer: 20160125Description: e316 p. digitalISSN:
  • 2044-5385
Subject(s):
  • Aminobenzoates -- administration & dosage
  • Animals
  • Antibodies, Monoclonal -- therapeutic use
  • Antigens, Neoplasm -- immunology
  • Antineoplastic Agents -- administration & dosage
  • Chromatography, Liquid
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Hematologic Neoplasms -- drug therapy
  • Humans
  • Immunotherapy -- methods
  • In Situ Hybridization
  • Mice
  • Mice, SCID
  • Oligopeptides -- administration & dosage
  • Tandem Mass Spectrometry
  • Tissue Array Analysis
  • Xenograft Model Antitumor Assays
Online resources:
  • Available from publisher's website
In: Blood cancer journal vol. 5
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 741
  • 742
  • 743
  • 744
  • 745
  • 746
  • 747
  • 748
  • 749
  • 750
  • 751
  • 752
  • 753
  • 754
  • 755
  • 756
  • 757
  • 758
  • 759
  • 760
  • 741 RIFM fragrance ingredient safety assessment, 4-Hexen-1-ol, (4Z)-, CAS Registry Number 928-91-6.
    by Api, A M
  • 742 RIFM FRAGRANCE INGREDIENT SAFETY ASSESSMENT phenylethyl 2-methylbutyrate, CAS Registry Number 24817-51-4.
    by Api, A M
  • 743 RIFM fragrance ingredient safety assessment 2-methyl-trans-2-butenoic acid, CAS Registry Number 80-59-1.
    by Api, A M
  • 744 RIFM fragrance ingredient safety assessment, Isolongifolene ketone, CAS registry number 23787-90-8.
    by Api, A M
  • 745 RIFM fragrance ingredient safety assessment cyclohexanecarboxylic acid, CAS Registry Number 98-89-5.
    by Api, A M
  • 746 RIFM fragrance ingredient safety assessment, coumarin, CAS Registry Number 91-64-5.
    by Api, A M
  • 747 RIFM fragrance ingredient safety assessment, methyl 3-hydroxyhexanoate, CAS Registry Number 21188-58-9.
    by Api, A M
  • 748 RIFM fragrance ingredient safety assessment, cis-3-hexenyl cis-3-hexenoate, CAS Registry Number 61444-38-0.
    by Api, A M
  • 749 RIFM fragrance ingredient safety assessment, dimethyl adipate, CAS Registry Number 627-93-0.
    by Api, A M
  • 750 RIFM fragrance ingredient safety assessment, p-tolyl acetate, CAS Registry Number 140-39-6.
    by Api, A M
  • 751 RIFM fragrance ingredient safety assessment, 1-cyclohexylethanol, CAS Registry Number 1193-81-3.
    by Api, A M
  • 752 RIFM fragrance ingredient safety assessment, 4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane, CAS Registry Number 68398-18-5.
    by Api, A M
  • 753 RIFM fragrance ingredient safety assessment, benzenemethanol, α-methylene-, acetate, CAS Registry Number 2206-94-2.
    by Api, A M
  • 754 RIFM fragrance ingredient safety assessment, methyl cyclohexadiene (mixture of isomers), CAS Registry Number 30640-46-1.
    by Api, A M
  • 755 RIFM fragrance ingredient safety assessment, cis-3-nonen-1-ol, CAS Registry Number 10340-23-5.
    by Api, A M
  • 756 RIFM fragrance ingredient safety assessment, acetic acid, anhydride, reaction products with 1,5,10-trimethyl-1,5,9-cyclododecatriene, CAS registry number 144020-22-4.
    by Api, A M
  • 757 RIFM fragrance ingredient safety assessment, methyl 2-nonynoate, CAS Registry Number 111-80-8.
    by Api, A M
  • 758 RIFM fragrance ingredient safety assessment, cyclohexanone, CAS Registry Number 108-94-1.
    by Api, A M
  • 759 RIFM fragrance ingredient safety assessment, 2-(4-methylphenoxy)-N-(1H-pyrazol-3-yl)-N-(thiophen-2-ylmethyl)acetamide, CAS Registry Number 1374760-95-8.
    by Api, A M
  • 760 RIFM fragrance ingredient safety assessment, 1-(5,5-dimethyl-1-cyclohexen-1-yl)pent-4-en-1-one, CAS Registry Number 56973-85-4.
    by Api, A M
Close

A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies.

APA

Kim S. Y., Theunissen J., Balibalos J., Liao-Chan S., Babcock M. C., Wong T., Cairns B., Gonzalez D., van der Horst E. H., Perez M., Levashova Z., Chinn L., D'Alessio J. A., Flory M., Bermudez A., Jackson D. Y., Ha E., Monteon J., Bruhns M. F., Chen G. & Migone T. (20160125). A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. : Blood cancer journal.

Chicago

Kim S Y, Theunissen J-W, Balibalos J, Liao-Chan S, Babcock M C, Wong T, Cairns B, Gonzalez D, van der Horst E H, Perez M, Levashova Z, Chinn L, D'Alessio J A, Flory M, Bermudez A, Jackson D Y, Ha E, Monteon J, Bruhns M F, Chen G and Migone T-S. 20160125. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. : Blood cancer journal.

Harvard

Kim S. Y., Theunissen J., Balibalos J., Liao-Chan S., Babcock M. C., Wong T., Cairns B., Gonzalez D., van der Horst E. H., Perez M., Levashova Z., Chinn L., D'Alessio J. A., Flory M., Bermudez A., Jackson D. Y., Ha E., Monteon J., Bruhns M. F., Chen G. and Migone T. (20160125). A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. : Blood cancer journal.

MLA

Kim S Y, Theunissen J-W, Balibalos J, Liao-Chan S, Babcock M C, Wong T, Cairns B, Gonzalez D, van der Horst E H, Perez M, Levashova Z, Chinn L, D'Alessio J A, Flory M, Bermudez A, Jackson D Y, Ha E, Monteon J, Bruhns M F, Chen G and Migone T-S. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. : Blood cancer journal. 20160125.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site